tiprankstipranks

Polly A. Murphy Insider Profile

4 Followers
Polly A. Murphy, Director at Atea Pharmaceuticals, holds 56.45K shares in Atea Pharmaceuticals (Ticker: AVIR), holds 5.00K shares in Celcuity (Ticker: CELC).
tipranks
Polly A. Murphy

Polly A. Murphy
Atea Pharmaceuticals (AVIR)
Director

Ranked #50,053 out of 99,335 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-1.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$256K
74.26%
25.74%
A breakdown of Polly A. Murphy's holdings

Insider Roles

Atea Pharmaceuticals
(AVIR)
Director
Celcuity
(CELC)
Director
Roles that Polly A. Murphy holds in companies

Most Profitable Insider Trade

Stock:
Celcuity
(CELC)
Rating:Informative Buy
Date:Nov 23, 2022 - Nov 23, 2023
Return:+44.00%
The most profitable trade made by Polly A. Murphy

Polly A. Murphy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Atea Pharmaceuticals
Jun 18, 2024
Director
Uninformative Buy
119.67K
$190.22K
Celcuity
Nov 23, 2022
Director
Informative Buy
48.35K
$65.95K
List of latest transactions for each holding click on a transaction to see Polly A. Murphy's performance on stock

Polly A. Murphy insider profile FAQ

What is the percentage of profitable transactions made by Polly A. Murphy?
The percentage of profitable transactions made by Polly A. Murphy is 50%.
    What is the average return per transaction made by Polly A. Murphy?
    The average return per transaction made by Polly A. Murphy is -1.20%.
      What stocks does Polly A. Murphy hold?
      Polly A. Murphy holds: AVIR, CELC stocks.
        What was Polly A. Murphy’s latest transaction?
        Polly A. Murphy latest transaction was an Uninformative Buy of $119.67K.
          What was Polly A. Murphy's most profitable transaction?
          Polly A. Murphy’s most profitable transaction was an Informative Buy of CELC stock on November 23, 2022. The return on the trade was 44.00%.
            What is Polly A. Murphy's role in Atea Pharmaceuticals?
            Polly A. Murphy's role in Atea Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.